![Brett R. Blackman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brett R. Blackman
Corporate Officer/Principal at
University of Virginia
Profile
Brett R.
Blackman was the founder of HemoShear Therapeutics, Inc. founded in 2008, where he held the title of Director & Chief Scientific Officer from 2008 to 2015.
Currently, he is an Associate Professor at the University of Virginia, and a Member of both the American Heart Association, Inc. and the Robert M Berne Cardiovascular Research Center.
Dr. Blackman's former jobs include Senior Vice President-Research at Evelo Biosciences, Inc. in 2016, Chief Scientific Officer at Omega Therapeutics, Inc. from 2018 to 2019, and Chief Scientific Officer at both Cogen Immune Medicine, Inc. and Senda Biosciences, Inc. from 2016 to 2018.
Dr. Blackman's education includes a doctorate from the University of Pennsylvania and an undergraduate degree from Drexel University.
Brett R. Blackman active positions
| Companies | Position | Start |
|---|---|---|
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 22/06/2010 |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Corporate Officer/Principal | 22/06/2010 |
Robert M Berne Cardiovascular Research Center | Corporate Officer/Principal | 22/06/2010 |
Former positions of Brett R. Blackman
| Companies | Position | End |
|---|---|---|
| OMEA THER | Chief Tech/Sci/R&D Officer | 31/05/2019 |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Chief Tech/Sci/R&D Officer | 31/10/2018 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Chief Tech/Sci/R&D Officer | 31/10/2018 |
| EVELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 30/09/2016 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Founder | 31/07/2015 |
Training of Brett R. Blackman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Health Services |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Robert M Berne Cardiovascular Research Center | |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
- Stock Market
- Insiders
- Brett R. Blackman
